The nationwide experiment will initially include around 100,000 volunteers.
The proteins drebin and EB3 are part of a “homing pathway” that helps cancer cells move from the prostate into the bloodstream or lymphatic system.
March 24, 2017|
(See A.E. Dart et al., “The drebrin/EB3 pathway drives invasive activity in prostate cancer,” Oncogene, doi:10.1038/onc.2017.45, 2017.)